Showing all 32 results
Altretamine Capsules
FreeAltretamine capsules are antineoplastic (chemotherapy) medications used primarily for the palliative treatment of advanced ovarian cancer. They are most commonly available in a 50 mg strength.
Chlorambucil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Low-Dose Cytotoxic Tablet, packed exclusively in light-shielded, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the sensitive aromatic mustard payload.
Active Ingredient Strength Primary Clinical Function Chlorambucil USP/Ph.Eur. 2 mg The Standard Hematology Anchor: The definitive unit utilized for chronic, daily maintenance and precise titration in CLL and low-grade lymphomas. Chlorambucil USP/Ph.Eur. 5 mg The Pulse-Dosing Payload: High-efficacy therapeutic payload utilized for “Pulse” therapy regimens or initial aggressive induction phases. Excipients Lactose Anhydrous / Colloidal Silicon Dioxide / Magnesium Stearate / Hypromellose / Titanium Dioxide / Premium Polymeric Film Diluent / Glidant / Lubricant / Protective Cytotoxic Shield (Engineered specifically utilizing an impenetrable film coat. This ensures the highly toxic, mutagenic API never comes into contact with the skin of the pharmacist or caregiver handling the medication). *Pack Sizes: 25-Tablet or 30-Tablet Bottles/Blisters (Optimized for oncology-specific treatment cycles).
Cisplatin Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Solution (Liquid) in amber glass vials.
Active Ingredient Strength Concentration Cisplatin USP/BP 10 mg Vial 1 mg/ml (10ml Vol) Cisplatin USP/BP 50 mg Vial 1 mg/ml (50ml Vol) Excipients Sodium Chloride / Mannitol Isotonicity / Diuresis *Pack Sizes: Tray of 1 Vial. (Cytotoxic Packaging).
Cyclophosphamide Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder for Injection in glass vials.
Active Ingredient Strength Primary Use Cyclophosphamide USP/BP 200 mg Vial Low Dose / Autoimmune Cyclophosphamide USP/BP 500 mg Vial Standard Chemotherapy Cyclophosphamide USP/BP 1000 mg (1 g) Vial High Dose / Hematology Excipients Mannitol / Sodium Chloride Bulking Agent (For Cake Structure) *Pack Sizes: Tray of 1 Vial, 10 Vials, or Box of 1/10 Vials.
Cyclophosphamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Cytotoxic Prodrug Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the sensitive nitrogen mustard derivative and to physically protect caregivers from API exposure.
Active Ingredient Strength Primary Clinical Function Cyclophosphamide USP/Ph.Eur.
(as Cyclophosphamide Monohydrate)50 mg The Oncology & Autoimmune Macrodose: The definitive oral therapeutic unit utilized for chronic, daily continuous “metronomic” chemotherapy regimens and severe immunosuppressive maintenance. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Starch / Magnesium Stearate / Heavy Sucrose or Polymeric Film-Coat Diluent / Densifier / Disintegrant / Lubricant / Protective Cytotoxic Shield (Engineered specifically utilizing a thick, impenetrable sugar or film coat to ensure the highly toxic API never comes into contact with the skin of the patient, pharmacist, or caregiver handling the pill) *Pack Sizes: Bottles of 50/100 or 10×10 Alu-Alu Blisters (Optimized specifically for strict chronic oncology and rheumatology dispensing regimens).
Cytarabine Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Solution (Liquid) or Lyophilized Powder.
Active Ingredient Strength Format Cytarabine USP/BP 100 mg / 5 ml (20 mg/ml) Ready-to-use Liquid Cytarabine USP/BP 500 mg / 10 ml (50 mg/ml) Ready-to-use Liquid Cytarabine USP/BP 1000 mg (1 g) Vial Lyophilized Powder or Conc. Liquid Excipients Water for Injection Preservative-Free (Available for IT use) *Pack Sizes: Tray of 1 Vial, 5 Vials, or Box of 1/10 Vials.
Dacarbazine Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder for Injection in amber glass vials to protect from light.
Active Ingredient Strength Therapeutic Role Dacarbazine USP/BP (DTIC) 200 mg Vial Standard Dose Dacarbazine USP/BP (DTIC) 500 mg Vial High Dose / Multi-use Excipients Citric Acid, Mannitol Stabilizers / pH Adjusters *Pack Sizes: Tray of 1 Vial, 10 Vials, or Box of 1/10 Vials.
Daunorubicin Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder for Injection in red-capped glass vials.
Active Ingredient Strength Appearance Daunorubicin Hydrochloride USP/BP Equivalent to 20 mg Daunorubicin Red-Orange Lyophilized Cake Excipients Mannitol Bulking Agent *Pack Sizes: Tray of 1 Vial. (Cytotoxic Packaging).
Erlotinib Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the targeted antineoplastic API.
Active Ingredient Strength Primary Clinical Function Erlotinib (as Hydrochloride) USP/Ph.Eur. 100 mg The Pancreatic Oncology Standard: The definitive daily maintenance dose utilized globally in combination with Gemcitabine for advanced, unresectable, or metastatic pancreatic cancer. Erlotinib (as Hydrochloride) USP/Ph.Eur. 150 mg The Thoracic Oncology Standard: Massive therapeutic payload utilized as a first-line, maintenance, or second-line daily monotherapy for EGFR-mutated Non-Small Cell Lung Cancer. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to maximize dissolution of this highly insoluble compound while locking the potent cytotoxic API safely inside the tablet, completely preventing handler exposure to carcinogenic dust) *Pack Sizes: 3×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Everolimus Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Antioxidant-Stabilized Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the highly oxidative, potent API.
Active Ingredient Strength Primary Clinical Function Everolimus USP/Ph.Eur. 0.25 mg / 0.5 mg / 0.75 mg Global Transplant Standard: Ultra-micro doses utilized for strict, lifelong immunosuppression following renal or hepatic allografts. Requires extreme content uniformity to maintain the narrow therapeutic blood trough levels (3 to 8 ng/mL). Everolimus USP/Ph.Eur. 5 mg / 10 mg Global Oncology Standard: Massive-dose antineoplastic payload utilized for the aggressive suppression of Renal Cell Carcinoma, Neuroendocrine Tumors (NETs), and HR+/HER2- Breast Cancer. Excipients Butylated Hydroxytoluene (BHT) / Hypromellose / Lactose Anhydrous / Crospovidone / Magnesium Stearate Antioxidant / Binder / Diluent / Superdisintegrant / Lubricant (Engineered specifically utilizing BHT (Butylated Hydroxytoluene) to prevent the rapid oxidative degradation of the Everolimus molecule, guaranteeing maximum clinical shelf-life and potency across harsh climates) *Pack Sizes: 10×10 Alu-Alu Blisters (Transplant) or 3×10 Alu-Alu Blisters (Oncology – 30 Day Supply).
Exemestane Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the potent steroidal antineoplastic agent.
Active Ingredient Strength Primary Clinical Function Exemestane USP/Ph.Eur. 25 mg Global Adult Oncology Standard: The definitive daily maintenance dose required to maintain absolute, continuous destruction of peripheral aromatase enzymes and keep estrogen levels crashed. Excipients Mannitol / Copovidone / Crospovidone / Sodium Starch Glycolate / Magnesium Stearate / Premium Polymeric Film Diluent / High-Shear Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to lock the highly potent, teratogenic steroidal API safely inside the tablet, completely preventing handler and pharmacist exposure to the hazardous dust) *Pack Sizes: 10×10 Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Flutamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the antiandrogen API.
Active Ingredient Strength Primary Clinical Function Flutamide USP/Ph.Eur. 250 mg Global Uro-Oncology Standard: The definitive therapeutic unit utilized for chronic, 8-hourly maintenance in Maximum Androgen Blockade (MAB) protocols. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to lock the potent antiandrogen API safely inside the tablet, completely preventing handler and pharmacist exposure to the hazardous hormonal dust) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict, high-volume chronic oncology dispensing regimens).
Fulvestrant Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Oily Solution in Prefilled Syringes (PFS) or Vials. (Note: This is a high-viscosity injection).
Active Ingredient Strength Volume Fulvestrant USP/BP 250 mg 5 ml Prefilled Syringe (50 mg/ml) Fulvestrant USP/BP 250 mg 5 ml Vial (50 mg/ml) Vehicle Castor Oil / Benzyl Alcohol Viscous Oily Base *Pack Sizes: Box of 1 PFS (with safety needles) or Box of 2 PFS (for 500mg dose).
Gefitinib tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the targeted antineoplastic agent.
Active Ingredient Strength Primary Clinical Function Gefitinib USP/Ph.Eur. 250 mg Global Adult Oncology Standard: The definitive, highly precise daily maintenance dose required to maintain constant, paralyzing pressure on the mutated EGFR protein to keep the lung cancer in deep molecular remission. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to maximize the dissolution of this poorly soluble compound while locking the cytotoxic API safely inside the tablet, completely preventing handler and pharmacist exposure to the carcinogenic dust) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Gemcitabine Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder for Injection in glass vials.
Active Ingredient Strength Primary Use Gemcitabine Hydrochloride USP/BP Equivalent to 200 mg Gemcitabine Low Dose / Adjustment Gemcitabine Hydrochloride USP/BP Equivalent to 1000 mg (1 g) Standard Adult Dose Gemcitabine Hydrochloride USP/BP Equivalent to 1400 mg (1.4 g) High Dose / Large BSA Excipients Mannitol / Sodium Acetate Bulking Agent / Buffer *Pack Sizes: Tray of 1 Vial. (Cytotoxic Packaging).
Hydroxyurea Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Scored Film-Coated Tablet, packed exclusively in highly secure, handler-protective Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure absolute chemical stability and prevent accidental cytotoxic exposure.
Active Ingredient Strength Primary Clinical Function Hydroxyurea USP/Ph.Eur. 200 mg / 300 mg / 400 mg Pediatric Sickle Cell Standard: Specialized weight-based units designed for exact mg/kg titration in infants and children suffering from severe vaso-occlusive crises. Hydroxyurea USP/Ph.Eur. 500 mg (Scored) Global Adult Hematology Standard: High-efficacy adult maintenance dose for CML, Polycythemia Vera, and adult Sickle Cell Disease. Excipients Microcrystalline Cellulose / Sodium Citrate / Crospovidone / Magnesium Stearate / Premium Polymeric Film Diluent / pH Stabilizer / Superdisintegrant / Slipper-Coating (Engineered specifically with a heavy, durable film-coat to completely seal the highly toxic, mutagenic core away from nurses, parents, and pharmacists) *Pack Sizes: Bottles of 100 or 10×10 Alu-Alu Blisters (Optimized specifically for massive-volume NGO procurement and chronic lifetime dispensing).
Imatinib Mesylate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the mesylate salt.
Active Ingredient Strength Primary Clinical Function Imatinib (as Mesylate) USP/Ph.Eur. 100 mg Pediatric & Titration Standard: Base therapeutic unit utilized for weight-based pediatric leukemia dosing, or for highly precise adult dose adjustments during acute hematological toxicity. Imatinib (as Mesylate) USP/Ph.Eur. 400 mg Global Adult Oncology Standard: High-efficacy adult maintenance dose, typically taken once daily for the chronic phase of CML, or twice daily for accelerated phases and GIST. Excipients Microcrystalline Cellulose / Crospovidone / Hypromellose / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Iron-Oxide Film Diluent / Superdisintegrant / Binder / Glidant / Heavy Film-Coating (Engineered specifically to lock the cytotoxic API safely inside the tablet, completely preventing handler and pharmacist exposure to the carcinogenic dust) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Letrozole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the micro-dosed endocrine disruptor.
Active Ingredient Strength Primary Clinical Function Letrozole USP/Ph.Eur. 2.5 mg Global Oncology & Fertility Standard: The universal therapeutic unit utilized for 5-to-10 year daily adjuvant breast cancer therapy, or short 5-day cyclic dosing for ovulation induction. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Superdisintegrant / Glidant / Slipper-Coating (Engineered specifically using elite geometric dilution to ensure the microscopic 2.5mg active payload is flawlessly distributed throughout the tablet, guaranteeing absolute content uniformity) *Pack Sizes: 10×10 Blisters or Bottles of 30 (Optimized specifically for strict, heavily monitored chronic oncology dispensing or monthly fertility cycles).
Melphalan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, handler-protective Amber Glass Bottles or specialized Alu-Alu cold-chain blisters to ensure the absolute chemical survival of the highly unstable alkylating agent.
Active Ingredient Strength Primary Clinical Function Melphalan USP/Ph.Eur. 2 mg Global Oncology Standard: Base therapeutic unit allowing for highly precise, weight-based or Body Surface Area (BSA) calculated “pulsed” dosing regimens. Excipients Microcrystalline Cellulose / Crospovidone / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Glidant / Slipper-Coating (Engineered specifically with a heavy film-coat to ensure immediate gastric transit and to completely seal the highly toxic, mutagenic core away from nurses and caregivers) *Pack Sizes: Amber Glass Bottles of 25/50 Tablets (Optimized specifically for strict, highly monitored hematology dispensing regimens).
Mercaptopurine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Tablet, packed exclusively in highly secure, handler-protective Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the antimetabolite and protect healthcare workers from cytotoxic exposure.
Active Ingredient Strength Primary Clinical Function Mercaptopurine (as Monohydrate) USP/Ph.Eur. 50 mg Global Oncology & Autoimmune Standard: Scored tablets allowing for highly precise, weight-based or Body Surface Area (BSA) based dose titrations in pediatric and adult populations. Excipients Lactose Monohydrate / Maize Starch / Pregelatinized Starch / Magnesium Stearate / Stearic Acid Diluent / Binder / Disintegrant / Lubricant (Engineered specifically using high-containment wet granulation to prevent airborne cytotoxic dust generation during manufacturing, ensuring precise, even API distribution) *Pack Sizes: Bottles of 25/50 or 10×10 Blisters (Optimized specifically for strict, heavily monitored chronic oncology dispensing regimens).
Morphine Sulphate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Extended-Release Matrix Tablet, packed exclusively in highly secure, tamper-evident Alu-PVC or Alu-Alu blister strips to ensure the absolute physical stability of the controlled-release polymers.
Active Ingredient Strength Primary Clinical Function Morphine Sulphate USP/Ph.Eur. 15 mg (SR) Initiation / Titration Standard: Base therapeutic unit for opioid-naïve patients starting around-the-clock chronic pain management. Morphine Sulphate USP/Ph.Eur. 30 mg / 60 mg (SR) Global Oncology Standard: High-dose adult maintenance therapy for severe, opioid-tolerant terminal cancer and intractable neuropathic pain. Excipients Hypromellose (HPMC) / Cetostearyl Alcohol / Lactose Monohydrate / Magnesium Stearate / Premium Color-Coded Film Hydrophilic Polymer / Lipophilic Retardant / Diluent / Lubricant (Engineered specifically to form an impenetrable, slow-eroding gel matrix in the GI tract, strictly metering the release of the narcotic over 12 hours) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic oncology dispensing regimens; frequently color-coded by strength to prevent fatal dispensing errors).
Ondansitron Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Flash-Dispersion ODT or Standard Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant peelable Alu-Alu blister strips to ensure the absolute chemical stability of the highly hygroscopic ODT matrix.
Active Ingredient Strength Primary Clinical Function Ondansetron (as HCl Dihydrate) Ph.Eur./USP 4 mg (ODT / FCT) Pediatric & PONV Standard: Base therapeutic unit for post-operative nausea, severe pediatric gastroenteritis, and mild emetic triggers. Ondansetron (as HCl Dihydrate) Ph.Eur./USP 8 mg (ODT / FCT) Global Oncology Standard: High-dose adult maintenance therapy for highly emetogenic chemotherapy (CINV) and radiation therapy (RINV). Excipients (ODT Formulation) Mannitol / Crospovidone / Aspartame / Colloidal Silicon Dioxide / Premium Mint Flavoring Lyophilized Matrix / Superdisintegrant / Sweetener / Saliva-Stimulating Flavor (Engineered specifically to draw saliva into the tablet matrix, forcing a violent, sub-5-second structural collapse on the tongue without a bitter aftertaste) *Pack Sizes: 10×10 Peelable Alu-Alu Blisters (Optimized specifically for strict oncology and surgical dispensing regimens).
Pazopanib Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, High-Density Film-Coated Tablet, packed exclusively in highly secure, child-resistant heavy-gauge HDPE bottles or specialized Alu-Alu blister strips to ensure the absolute chemical stability of the cytotoxic molecule and prevent accidental exposure.
Active Ingredient Strength Primary Clinical Function Pazopanib HCl INN/Ph.Eur. 200 mg (Base Equivalent) Dose-Modification Standard: Essential unit for precise dose reduction in patients experiencing severe hepatic toxicity or adverse drug reactions. Pazopanib HCl INN/Ph.Eur. 400 mg (Base Equivalent) Global Clinical Standard: Primary therapeutic unit designed to achieve the massive 800 mg daily protocol with minimal pill burden. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K30 / Magnesium Stearate / Hypromellose / Titanium Dioxide Diluent / Superdisintegrant / Binder / Lubricant / Premium Cytotoxic-Barrier Film-Coating (Engineered specifically to seal the lethal HPAPI inside the tablet, completely protecting healthcare workers and caregivers from highly toxic dust exposure) *Pack Sizes: Bottles of 30 or 60 Tablets (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Sorafenib Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, child-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute stability of the tosylate salt formulation.
Active Ingredient Strength Primary Clinical Function Sorafenib Tosylate INN/Ph.Eur. 200 mg (Equivalent to Sorafenib free base) Global Standard: Base titration unit for the standard 800 mg daily oncology regimen. Excipients Croscarmellose Sodium / Microcrystalline Cellulose / Hypromellose / Magnesium Stearate Superdisintegrant / Diluent / Film-Coating (Engineered for strict gastric dissolution and reliable systemic bioavailability) Tamoxifen Citrate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips to preserve the integrity of the highly sensitive hormonal API.
Active Ingredient Strength Primary Clinical Use Tamoxifen Citrate USP/Ph.Eur. 10 mg (Equivalent to Tamoxifen Base) Standard divided-dose therapy and specific prophylactic risk-reduction protocols. Tamoxifen Citrate USP/Ph.Eur. 20 mg (Equivalent to Tamoxifen Base) Global Standard: Target once-daily adult maintenance dose for ER+ breast cancer. Excipients Mannitol / Maize Starch / Magnesium Stearate / Croscarmellose Sodium Diluent / Superdisintegrant (Engineered for immediate gastric dispersion and reliable absorption) Tamoxifen Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated or Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips to preserve the integrity of the highly sensitive hormonal API.
Active Ingredient Strength Primary Clinical Use Tamoxifen Citrate USP/Ph.Eur. 10 mg Standard divided-dose therapy and specific risk-reduction protocols. Tamoxifen Citrate USP/Ph.Eur. 20 mg Global Standard: Target once-daily adult maintenance dose for ER+ breast cancer. Excipients Mannitol / Maize Starch / Magnesium Stearate / Croscarmellose Sodium Diluent / Superdisintegrant (Engineered for immediate gastric dispersion and reliable absorption) Temozolamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Hard Gelatin Capsule, packed in highly secure, child-resistant and moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles. We offer the complete range of strengths required for exact, weight-based (Body Surface Area) oncology dosing.
Active Ingredient Strength Primary Clinical Use Temozolomide INN/Ph.Eur. 20 mg Micro-dosing for strict Body Surface Area (BSA) rounding and pediatric protocols. Temozolomide INN/Ph.Eur. 100 mg / 140 mg Standard titration strengths for concurrent radiotherapy and maintenance phases. Temozolomide INN/Ph.Eur. 250 mg High-dose foundation for the 5-day maintenance cycle in adult GBM patients. Excipients Lactose Anhydrous / Colloidal Silicon Dioxide / Sodium Starch Glycolate / Stearic Acid Diluent / Glidant / Superdisintegrant (Engineered for immediate gastric capsule dissolution) Temozolomide Capsules
FreeTemozolomide capsules are oral chemotherapy agents used primarily to treat specific types of brain tumours, such as glioblastoma multiforme and anaplastic astrocytoma. Because temozolomide is a hazardous drug, the capsules are designed to be swallowed whole to prevent direct exposure to the potent active ingredient.
Thioguanine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Scored Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles, engineered to maintain absolute stability and physical containment of the cytotoxic agent.
Active Ingredient Strength Primary Clinical Use Thioguanine USP/Ph.Eur. 40 mg Standard Adult/Pediatric Dose (Titrated by Body Surface Area or Weight) for AML and ALL. Excipients Lactose Monohydrate / Potato Starch / Magnesium Stearate / Stearic Acid Diluent / Glidant (Engineered for immediate gastric dispersion and precise tablet splitting) Vinblastine Sulphate Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder (White to Off-White) or as a Ready-to-Use Liquid Solution in glass vials.
Active Ingredient Strength & Format Reconstitution / Dilution Vinblastine Sulphate USP/BP 10 mg / 10 ml (Liquid) Ready-to-use solution (1 mg/ml). Requires further dilution in 0.9% NaCl before infusion. Vinblastine Sulphate USP/BP 10 mg (Lyophilized Powder) Requires exactly 10 ml of Bacteriostatic 0.9% Sodium Chloride to yield 1 mg/ml. Excipients Sodium Chloride / Water for Injection Isotonicity / Solvent System *Pack Sizes: Single Vial encased in specialized protective cytotoxic shrink-wrap
Vincristine Sulphate Injection
FreeVincristine sulphate injection (often known by the brand Oncovin) is a sterile, preservative-free solution of a vinca alkaloid chemotherapy agent derived from the periwinkle plant. It is a clear, colourless liquid typically supplied in 1 mg or 2 mg vials.
